Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Illuminating Glial Dysfunction in Alzheimer's Disease With Optical Coherence Tomography
Sponsor: University of California, Davis + National Institute on Aging (NIA)
No open prediction endpoints
Endpoints are classified and published by ProgramSignal analysts.
Request endpoint coverageKey Facts
Primary Endpoints (CT.gov)
Light-dependent Change in Optical Coherence Tomography Images
Time frame: Day 1 (less than two hours)
Eligibility Criteria
Inclusion Criteria: * By clinician (or prior research) assessment, known to either be cognitively normal, or have mild cognitive impairment * Known Alzheimer's biomarker status. As of 2023-JUL, this must either be an amyloid PET scan, or cerebrospinal fluid measurement of amyloid and tau levels. * NOTE: Although this is a study of the eyes, age-typical ocular/vision complaints are permissible, so long as the the retina is thought to be healthy. This list of acceptable conditions includes most people who: * wear glasses * wear contacts * use over-the-counter eye drops * have mild cataracts (no surgery scheduled) * had cataracts removed * had eye muscle surgery (e.g., to correct eye misalignment) * had eyelid surgery (blepharoplasty) * are monitored by an ophthalmologist in case a problem with the retina develops (this is sometimes suggested for people with diabetes), but one or both retinas is/are thought to be completely healthy Exclusion Criteria: * Pregnant women …
Read full criteria on CT.gov →✦ Analyst Commentary
Expert commentary on why this trial matters and what to watch for.
Request coverage →